• The Scaly-foot snail (Chrysomallon squamiferum) is one of the most extraordinary deep-sea creatures known to science.

    It lives in extreme environments near hydrothermal vents, specifically in the Indian Ocean, where temperatures can approach 400°C (750°F).

    What sets this snail apart is its triple-layered shell, which includes:

    1. An outer layer of iron sulfide, making it the only known animal to incorporate iron into its skeleton.

    2. A middle layer of organic material, acting as a shock absorber.

    3. An inner aragonite layer, a typical component in many mollusk shells.

    Its scales (or "sclerites"), which also contain iron sulfide, cover its foot—hence the name "scaly-foot"—and may protect it from predators like venomous snails or extreme heat.

    This armor-like adaptation helps the snail survive in an environment with high pressure, toxic chemicals, and temperatures that would kill most life forms.

    Scientists believe the snail’s shell design could inspire future materials for defense or engineering, due to its resistance to mechanical and thermal stress.

    The Scaly-foot snail has also been recognized as endangered by the IUCN because of the increasing threat of deep-sea mining in its limited habitat.
    The Scaly-foot snail (Chrysomallon squamiferum) is one of the most extraordinary deep-sea creatures known to science. It lives in extreme environments near hydrothermal vents, specifically in the Indian Ocean, where temperatures can approach 400°C (750°F). What sets this snail apart is its triple-layered shell, which includes: 1. An outer layer of iron sulfide, making it the only known animal to incorporate iron into its skeleton. 2. A middle layer of organic material, acting as a shock absorber. 3. An inner aragonite layer, a typical component in many mollusk shells. Its scales (or "sclerites"), which also contain iron sulfide, cover its foot—hence the name "scaly-foot"—and may protect it from predators like venomous snails or extreme heat. This armor-like adaptation helps the snail survive in an environment with high pressure, toxic chemicals, and temperatures that would kill most life forms. Scientists believe the snail’s shell design could inspire future materials for defense or engineering, due to its resistance to mechanical and thermal stress. The Scaly-foot snail has also been recognized as endangered by the IUCN because of the increasing threat of deep-sea mining in its limited habitat.
    0 Reacties 0 aandelen 21K Views
  • Taking a trip! And, paying tribute to one of our favorite 'MJ' artists, @CarlosGomezArtist! No matter what Marvel spins up, he always does her right...! #MaryJaneWatson #SpiderMan #CarlosGomez #AllNewVenom #BlueOctober #Dallas #FortWorth #DFW

    「Next: 6/5 • @BlueOctoberBand @TannahillsTavernFTX • Fort Worth, TX」

    MJ: MJ of @MJ_and_Spidey
    Image: Spidey SONY α7III
    Inspired by @CarlosGomezArtist

    __________

    #MJandSpidey #TheAmazingMaryJane #MaryJane #Venom #MaryJaneWatsonCosplay #PeterParker #UltimateSpiderMan #AmazingSpiderMan #SpiderManCosplay #SpiderVerse #Marvel #FantasticFour #MarvelComics #Comicbooks #ComicArt #Cosplay #SciFi #CosplayGirl #Redhead #Model #Heels #RockAndRoll

    「2025.0602」   𝙈𝙅 𝙖𝙣𝙙 𝙎𝙖𝙫𝙖𝙣 𝘽𝙚𝙘𝙠𝙚𝙧 🕸 IG:mj_and_spidey
    Taking a trip! ✈️😊🎶 And, paying tribute to one of our favorite 'MJ' artists, @CarlosGomezArtist! No matter what Marvel spins up, he always does her right...! ❤️ #MaryJaneWatson #SpiderMan #CarlosGomez #AllNewVenom 🕸️ #BlueOctober #Dallas #FortWorth #DFW 「Next: 6/5 • @BlueOctoberBand @TannahillsTavernFTX • Fort Worth, TX」 MJ: MJ of @MJ_and_Spidey Image: Spidey 📷 SONY α7III Inspired by @CarlosGomezArtist 🎨 __________ #MJandSpidey #TheAmazingMaryJane #MaryJane #Venom #MaryJaneWatsonCosplay #PeterParker #UltimateSpiderMan #AmazingSpiderMan #SpiderManCosplay #SpiderVerse #Marvel #FantasticFour #MarvelComics #Comicbooks #ComicArt #Cosplay #SciFi #CosplayGirl #Redhead #Model #Heels #RockAndRoll 「2025.0602」 👠💋  𝙈𝙅 𝙖𝙣𝙙 𝙎𝙖𝙫𝙖𝙣 𝘽𝙚𝙘𝙠𝙚𝙧 🕸📷 IG:mj_and_spidey
    0 Reacties 0 aandelen 20K Views
  • A groundbreaking study published by researchers at the Harry Perkins Institute of Medical Research in Australia revealed that melittin, the active compound in honeybee venom, can selectively kill aggressive breast cancer cells, including triple-negative breast cancer (TNBC) and HER2-enriched types.

    These types are particularly difficult to treat due to their resistance to conventional therapies.

    Key findings include:

    Melittin disrupted the cancer cells’ plasma membranes and interfered with signaling pathways essential for tumor growth.

    Within 60 minutes, melittin was able to significantly reduce the viability of cancer cells.

    Most notably, the venom did not affect normal breast cells, highlighting its therapeutic potential.

    The study also suggested combination therapy with chemotherapy, showing enhanced effectiveness.

    However, it's important to note that this research is still in the preclinical phase, primarily conducted in lab settings and mice.

    Further clinical trials in humans are necessary to confirm its safety and efficacy before being considered a treatment option.
    A groundbreaking study published by researchers at the Harry Perkins Institute of Medical Research in Australia revealed that melittin, the active compound in honeybee venom, can selectively kill aggressive breast cancer cells, including triple-negative breast cancer (TNBC) and HER2-enriched types. These types are particularly difficult to treat due to their resistance to conventional therapies. Key findings include: Melittin disrupted the cancer cells’ plasma membranes and interfered with signaling pathways essential for tumor growth. Within 60 minutes, melittin was able to significantly reduce the viability of cancer cells. Most notably, the venom did not affect normal breast cells, highlighting its therapeutic potential. The study also suggested combination therapy with chemotherapy, showing enhanced effectiveness. However, it's important to note that this research is still in the preclinical phase, primarily conducted in lab settings and mice. Further clinical trials in humans are necessary to confirm its safety and efficacy before being considered a treatment option.
    0 Reacties 0 aandelen 15K Views
  • I am on hour 13 in the ICU with a Mojave Rattlesnake bite. I have had 20 vials of anti venom and expect some more.
    I am on hour 13 in the ICU with a Mojave Rattlesnake bite. I have had 20 vials of anti venom and expect some more.
    0 Reacties 0 aandelen 23K Views